Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mégane Pons"'
Autor:
Mégane Pons, Ludovic Jean, Sylvain Routier, Frédéric Buron, Sylvie Chalon, Pierre-Yves Renard
Publikováno v:
Proceedings, Vol 22, Iss 1, p 88 (2019)
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available therapy is limited to symptomatic treatment, and its efficacy remains unsatisfactory. In view of the prevalence and expected increase in the incidence o
Externí odkaz:
https://doaj.org/article/7aa0458ce722468585e13d8143bf8117
Autor:
Mattia Ricchini, Nicolas Coquelle, Nibaldo C. Inestrosa, Vincenza Andrisano, Florian Nachon, Belén Pérez, Ludovic Jean, Maria Luisa García, Diego Muñoz-Torrero, Pierre-Yves Renard, Elisabet Viayna, Pedro Cisternas, Monika Cieslikiewicz-Bouet, Antoni Camins, Carolina A. Oliva, Xavier Brazzolotto, Mégane Pons, Israel Silman, Angela De Simone, Luciano Saso, Jacques-Philippe Colletier, Miren Ettcheto, Manuela Bartolini, Elena Sánchez-López, Marisa Rendina, Omidreza Firuzi
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2020, ⟨10.1021/acs.jmedchem.0c01775⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Medicinal Chemistry, 2020, ⟨10.1021/acs.jmedchem.0c01775⟩
Journal of Medicinal Chemistry, American Chemical Society, 2020, ⟨10.1021/acs.jmedchem.0c01775⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Medicinal Chemistry, 2020, ⟨10.1021/acs.jmedchem.0c01775⟩
The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66750f0fe3dc20931ab17df68c4b4b3
http://hdl.handle.net/11585/790319
http://hdl.handle.net/11585/790319
Autor:
Ludovic Jean, Pierre-Yves Renard, Sylvie Chalon, Frederic Buron, Mégane Pons, Sylvain Routier
Publikováno v:
Proceedings
Proceedings, MDPI, 2019, 22 (1), pp.88. ⟨10.3390/proceedings2019022088⟩
Proceedings, 2019, 22 (1), pp.88. ⟨10.3390/proceedings2019022088⟩
Proceedings, Vol 22, Iss 1, p 88 (2019)
Proceedings, MDPI, 2019, 22 (1), pp.88. ⟨10.3390/proceedings2019022088⟩
Proceedings, 2019, 22 (1), pp.88. ⟨10.3390/proceedings2019022088⟩
Proceedings, Vol 22, Iss 1, p 88 (2019)
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available therapy is limited to symptomatic treatment, and its efficacy remains unsatisfactory. In view of the prevalence and expected increase in the incidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f296b102bf2f99ccc8c2ac2606a1590
https://hal-normandie-univ.archives-ouvertes.fr/hal-02352595
https://hal-normandie-univ.archives-ouvertes.fr/hal-02352595